VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
174 hedge funds and large institutions have $819M invested in Verve Therapeutics in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 50 increasing their positions, 68 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 57
26% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 68
86% less call options, than puts
Call options by funds: $5.84M | Put options by funds: $41.9M
Holders
174
Holding in Top 10
3
Calls
$5.84M
Puts
$41.9M
Top Buyers
| 1 | +$38.3M | |
| 2 | +$15.6M | |
| 3 | +$15.4M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$9.96M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.91M |
Top Sellers
| 1 | -$31.6M | |
| 2 | -$15.7M | |
| 3 | -$13.7M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$12.6M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$11.4M |